Advanced
Anesthesiolog
y
Pharmacology:
The Elite Test
Bank
PART 0: THE NAVIGATOR
● PART I: THE PRIMER
○ The "Welcome to the Big Leagues" Hook
○ The "Panic Button" Cheat Sheet
● PART II: THE ELITE TEST BANK
○ Section A: Foundational Syntax & Application (Questions 1–15)
■ Focus: Preoperative GLP-1/SGLT2 Guidelines, LAST Protocols, Malignant
, Hyperthermia, Basic NMB Standards.
○ Section B: Professional Simulation (Questions 16–40)
■ Focus: Sugammadex in Special Populations, Novel Sedatives (Ciprofol,
Remimazolam), ASRA Anticoagulation, Fascial Plane Blocks.
○ Section C: Grandmaster Synthesis (Questions 41–66)
■ Focus: CICV Emergencies, Geriatric Polypharmacy, Environmental
Stewardship, AI Integration, High-Acuity Obstetric Pharmacology.
PART I: THE PRIMER
Mastery of advanced anesthesiology pharmacology transforms the competent practitioner into
an indispensable diagnostician who anticipates physiological collapse before the first alarm
sounds. You are here to forge deep, practical intuition that directly intercepts high-stakes clinical
crises and prevents fatal medication errors in the evolving 2026/2027 healthcare landscape.
● The GLP-1 Mandate: Weekly GLP-1 agonists must be held for 7 days prior to elective
surgery regardless of the indication (weight loss or diabetes).
● The 2026 NMB Extubation Rule: Subjective twitch assessment is obsolete; quantitative
monitoring requires an absolute minimum Train-of-Four (TOF) ratio ≥0.9 prior to pulling
the endotracheal tube.
● The LAST Directive: Never administer propofol during Local Anesthetic Systemic Toxicity
seizures; use benzodiazepines to stop the seizure while preserving the failing
cardiovascular system.
● The Environmental Law: Desflurane and centralized nitrous oxide are clinically
deprecated due to extreme global warming potential; leverage TIVA or Sevoflurane.
PART II: THE ELITE TEST BANK
Section A: Foundational Syntax & Application
Q1: A 55-year-old patient taking weekly subcutaneous semaglutide for weight loss presents for
elective cholecystectomy. According to the 2026 ASA consensus guidelines, what is the MOST
APPROPRIATE INITIAL management regarding this medication? A) Continue the medication
and proceed with a rapid sequence induction. B) Hold the medication for 3 days prior to surgery
to prevent aspiration. C) Hold the medication for one week prior to the procedure, irrespective of
the indication. D) Switch the patient to a daily GLP-1 agonist for the perioperative period.
● The Answer: C (Hold the medication for one week prior to the procedure, irrespective of
the indication.)
● Distractor Analysis:
○ A is incorrect: Continuing a weekly GLP-1 agonist increases the risk of delayed
gastric emptying and aspiration.
○ B is incorrect: A 3-day hold is the standard for most SGLT2 inhibitors, not weekly
GLP-1 agonists.
○ D is incorrect: Bridging with daily GLP-1 agonists is not recommended; an
endocrinologist should manage bridging if required for glycemic control, not weight
loss.
The Mentor's Analysis: GLP-1 agonists paralyze the gastric emptying process. The 2026 ASA
guidelines mandate a 7-day hold for weekly formulations because aspiration risk does not care
, if the drug is for diabetes or weight loss. Professional Intuition: Treat every GLP-1 patient as a
"full stomach" until proven otherwise by gastric ultrasound.
Medication Class Drug Example 2026 ASA Fasting/Hold Indication
Guideline
GLP-1 Agonist Semaglutide Hold 7 days prior to Diabetes / Weight Loss
(Weekly) (Ozempic/Wegovy) procedure
GLP-1 Agonist (Daily) Liraglutide (Victoza) Hold day of procedure Diabetes / Weight Loss
SGLT2 Inhibitor Empagliflozin Hold 3 days prior to Diabetes / Heart Failure
procedure
SGLT2 Inhibitor Ertugliflozin Hold 4 days prior to Diabetes
procedure
Q2: A patient develops severe muscle rigidity, tachycardia, and rapidly increasing ETCO2
shortly after the administration of succinylcholine and isoflurane. The practitioner reaches for the
stocked Ryanodex. What is the FIRST step in preparing this specific medication? A)
Reconstitute each 20 mg vial with 60 mL of sterile water. B) Reconstitute each 250 mg vial with
5 mL of sterile water. C) Dilute the suspension in 1000 mL of 0.9% normal saline. D) Administer
2.5 mg/kg IV push directly without reconstitution.
● The Answer: B (Reconstitute each 250 mg vial with 5 mL of sterile water.)
● Distractor Analysis:
○ A is incorrect: This is the reconstitution protocol for legacy Dantrium/Revonto, which
wastes critical time during a crisis.
○ C is incorrect: Ryanodex must be reconstituted with sterile water, not saline, to
prevent precipitation.
○ D is incorrect: It is an injectable suspension that absolutely requires reconstitution
before administration.
The Mentor's Analysis: Ryanodex revolutionized Malignant Hyperthermia management by
drastically reducing the fluid volume and mixing time required. However, its high pH carries a
high risk of tissue necrosis if extravasation occurs. Professional Intuition: In an MH crisis,
seconds are tissue; know your specific formulation's dilution matrix blindly to avoid delaying the
antidote.
Q3: During a regional nerve block, a patient begins seizing, indicating Local Anesthetic
Systemic Toxicity (LAST). According to the 2026 ASRA guidelines, which medication must the
practitioner IMMEDIATELY AVOID administering? A) Midazolam B) Propofol C) Lipid Emulsion
20% D) Low-dose Epinephrine
● The Answer: B (Propofol)
● Distractor Analysis:
○ A is incorrect: Benzodiazepines are the preferred treatment to terminate
LAST-induced seizures.
○ C is incorrect: Lipid emulsion is the definitive rescue therapy for LAST.
○ D is incorrect: Low-dose epinephrine (<1 mcg/kg) is appropriate if cardiac arrest
occurs, though high doses are avoided.
The Mentor's Analysis: Propofol is a potent cardiovascular depressant. In a LAST crisis, the
myocardium is already poisoned and hanging by a thread. Hitting it with a standard induction
dose of propofol to stop a seizure will precipitate immediate cardiovascular collapse.
Professional Intuition: Stop the brain electrically (with benzodiazepines) without crashing the
heart mechanically.
Q4: A 68-year-old patient with type 2 diabetes and chronic kidney disease is scheduled for